Title:
ＦＸＲ受容体作動薬としてのラクタム系化合物
Document Type and Number:
Japanese Patent JP7266538
Kind Code:
B2
Abstract:
Disclosed is a compound as shown in formula (I), an optical isomer thereof or a pharmaceutically acceptable salt thereof, and the present invention relates to the use of same in the preparation of a drug for treating FXR-related diseases.
Inventors:
Kakaitaka
Surplus army
Chen Akebono
Surplus army
Chen Akebono
Application Number:
JP2019565423A
Publication Date:
April 28, 2023
Filing Date:
May 25, 2018
Export Citation:
Assignee:
CSPC ZHONGQI PHARMACEUTICAL TECHNOLOGY(SHIJIAZHUANG)CO.,Ltd.
International Classes:
C07D413/12; A61K31/422; A61K31/427; A61K31/4439; A61K31/4709; A61P1/16; C07D413/14; C07D417/14
Domestic Patent References:
| JP2006514069A | ||||
| JP2003507327A | ||||
| JP5502022A |
Foreign References:
| WO2005054213A1 |
Attorney, Agent or Firm:
Saegusa International Patent Office
Previous Patent: How to use the connected lighting system
Next Patent: Method for producing renewable base oil, diesel and naphtha
Next Patent: Method for producing renewable base oil, diesel and naphtha